Related Experiment Video
Updated: Jan 9, 2026

15:48
Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging
Published on: December 15, 2014
23.0K
Multiparametric MRI Markers Associated with Breast Cancer Risk in Women with Dense Breasts
Wesley Surento1,2, Romy Fischer1,3, Debosmita Biswas1,4
1Department of Radiology, University of Washington, Seattle, WA 98195, USA.
Cancers
|December 11, 2025
Summary
Quantitative multiparametric MRI measures, including background parenchymal enhancement (BPE) to breast and fibroglandular tissue (FGT) to breast ratios, can help identify high-risk women with dense breasts. These imaging markers show potential for improving breast cancer risk assessment.
Area of Science:
- Radiology
- Oncology
- Medical Imaging
Background:
- Dense breasts pose challenges for mammography and increase breast cancer risk.
- Multiparametric MRI offers detailed tissue characterization beyond standard imaging.
- Understanding normal tissue MRI features can aid in risk stratification.
Purpose of the Study:
- To investigate associations between normal breast tissue characteristics on multiparametric MRI and clinical breast cancer risk assessments.
- To evaluate quantitative MRI markers for differentiating high-risk from low-risk women with dense breasts.
Main Methods:
- Inclusion of women with dense breasts who underwent multiparametric MRI.
- Breast cancer risk assessment using Tyrer-Cuzick (TC) lifetime risk scores (high: ≥20%, low: <20%).
- Calculation of quantitative imaging markers: BPE:breast ratio, FGT:breast ratio, BPE:vessel ratio, and qualitative BPE.
Main Results:
- Quantitative MRI markers, specifically BPE:breast ratio, FGT:breast ratio, and BPE:vessel ratio, were significantly associated with higher breast cancer risk.
- Qualitative background parenchymal enhancement (BPE) assessment did not show a significant association with risk.
- Risk categorization based on imaging markers showed up to 70% concordance with TC risk scores.
Conclusions:
- Quantitative multiparametric MRI measures can moderately discriminate between high- and low-risk groups in women with dense breasts.
- These imaging biomarkers hold promise for supplementing existing breast cancer risk assessment tools.
- Further research is warranted to validate the clinical utility of these quantitative MRI markers.

